Portfolio

Top Stocks

Quarterly Top 10 Holdings

as of 31-Mar-2017

GW Pharmaceuticals Plc 10.69%
Scotts Miracle-Gro Comapny (The) 10.01%
Abbott Laboratories 5.36%
Zynerba Pharmaceuticals Inc. 5.09%
Microsoft Corporation 5.04%
MassRoots Inc. 4.95%
Cara Therapeutics Inc. 4.71%
Merck & Company Inc. 4.54%
Cannabis Sativa Inc. 4.53%
Cannabis Science Inc. 4.36%

Top Portfolio Holdings

as of 31-Mar-2017

1. GW Pharmaceuticals PLC (GWPH)
GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
2. Scotts Miracle-Gro Company (SMG)
Hydroponics is the process of growing plants in liquids without the use of soil and is a popular method for cultivating marijuana.
3. Abbott Laboratories (ABT)
Manufactures Dexanabinol: A synthetic cannabinoid that protects the brain from damage (cardiac surgery), regain memory and other high-level functions following traumatic brain injury. Possible future use as an anti-cancer drug.
4. Zynerba Pharmaceuticals Inc (ZYNE)
In development of two long term medical treatments.
5. Microsoft Corp (MSFT)
Microsoft is developing a new product in Microsoft's cloud computing business that is meant to help states that have legalized the medical or recreational use of marijuana. The software is meant to keep tabs on sales and commerce, ensuring that they remain in the daylight of legality.
6. MassRoots Inc (MSRT)
One of the leading technology platforms for the cannabis industry
7. Cara Therapeutics Inc. (CARA)
Cara is developing lead molecules that selectively modulate peripheral CB receptors without targeting CNS cannabinoid receptors.
8. Merck & Company Inc. (MRK)
Looking to acquire marijuana based drug companies.
9. Cannabis Stavia Inc (CBDS)
Cannabis Sativa Inc and its subsidiary are engaged in research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
10. Cannabis Science Inc. (CBIS)
Engaged in research, development, and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.